Back to Trades
Anderson Kenneth Carl
DirectorCIK 0001824862
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 7 filings between 2025–2026, Anderson Kenneth Carl, Director, has disclosed $325.5K in transactions — all concentrated in C4 Therapeutics, Inc. (CCCC). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Oct 2 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Grant | $11.5K |
| Jul 2 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Grant | $11.5K |
| Jun 26 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Award | $263.5K |
| Jun 4 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Exercise | $4.5K |
| Apr 3 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Grant | $11.5K |
| Jan 5 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Grant | $11.5K |
| Oct 3 | CCCC C4 Therapeutics, Inc. | Anderson Kenneth Carl | Director | Grant | $11.5K |
7 filings